ClinicalTrials.Veeva

Menu

Interaction of Apelin and Angiotensin in the Human Forearm Circulation

U

University of Edinburgh

Status

Completed

Conditions

Vasodilation
Heart Disease

Treatments

Drug: Noradrenaline infusion
Drug: Angiotensin II

Study type

Interventional

Funder types

Other

Identifiers

NCT00901745
FS/09/019/26905 - 1b

Details and patient eligibility

About

The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease.

Apelin has the ability to cause blood vessels to relax, increasing their diameter and hence blood flow down the blood vessel. The researchers wish to investigate the hypothesis that an infusion of apelin will reduce the effects of angiotensin II, which is know to reduce the diameter of blood vessels.

Enrollment

12 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • > 18 years old
  • Healthy volunteers

Exclusion criteria

  • Lack of informed consent

  • Age < 18 years,

  • Current involvement in other research studies,

  • Systolic blood pressure >190 mmHg or <100 mmHg

  • Malignant arrhythmias

  • Renal or hepatic failure

  • Haemodynamically significant aortic stenosis

  • Severe or significant co morbidity

  • Women of childbearing potential.

  • Any regular medication

    • Previous history of any cardiovascular disease

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

12 participants in 2 patient groups

Infusion of apelin
Experimental group
Description:
Using forearm venous occlusion plethysmography apelin will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.
Treatment:
Drug: Angiotensin II
Drug: Noradrenaline infusion
Sodium nitroprusside infusion
Active Comparator group
Description:
Using forearm venous occlusion plethysmography sodium nitroprusside will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.
Treatment:
Drug: Angiotensin II
Drug: Noradrenaline infusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems